News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-11 5:18:40 pm SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX PRNewsWire
2024-02-22 1:21:32 am 13 Best Falling Stocks To Buy Right Now Insider Monkey
2024-02-12 4:4:31 am UPDATE 1-AN2 Therapeutics to pause lung disease study enrollment Reuters
2024-02-12 3:54:42 am AN2 Therapeutics to pause lung disease study enrollment Reuters
2024-02-12 3:45:0 am AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivotal Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease Business Wire
2024-02-01 4:29:30 am We're Not Very Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate Simply Wall St.
2024-01-30 1:10:0 pm AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference Business Wire
2024-01-12 12:2:11 am AN2 Therapeutics Inc Chief Strategy Officer Kevin Krause Sells 7,417 Shares GuruFocus.com
2024-01-10 5:50:6 am Recent Price Trend in AN2 Therapeutics, Inc. (ANTX) is Your Friend, Here's Why Zacks
   

Please consider a small donation if you think this website provides you with relevant information